Fisher David 4

What Happened
David Fisher, Executive Chairman and Director of Enova International (ENVA), exercised/converted derivative awards and sold the underlying 9,573 shares on January 26, 2026. He exercised at $23.96 per share (exercise cost $229,369) and sold the same 9,573 shares in the open market at a weighted-average price of $157.81 per share for gross proceeds of $1,510,667. The filing shows a related derivative disposition at $0.00 consistent with the tandem SAR/option mechanics disclosed in the footnotes.

Key Details

• Transaction date: 2026-01-26; Form 4 filed 2026-01-28 (timely within standard 2-business-day window).
• Exercise: 9,573 shares @ $23.96 each (total exercise cost $229,369). Code M (exercise/conversion of derivative).
• Sale: 9,573 shares @ weighted avg $157.81 each (gross proceeds $1,510,667). Reported price range for trades: $156.28–$158.8925.
• Footnote F1: Sale executed under a Rule 10b5-1 trading plan.
• Footnotes F3–F5: The SAR and option were granted in tandem (exercise of one causes expiration of the other); vesting schedule and SAR mechanics are described in the filing.
• Shares owned after transaction: not disclosed in the provided filing excerpt.

Context
This was effectively a cashless-style transaction: Fisher paid the exercise cost and sold the resulting shares the same day, realizing gross proceeds of about $1.51M (exercise cost was ~$229k). The sale was executed pursuant to a pre-arranged 10b5-1 plan, which typically indicates the trades were pre-scheduled rather than opportunistic. The filing includes a derivative entry and footnotes explaining a paired SAR/option structure—readers should review the full Form 4 or contact the issuer/SEC staff for the complete mechanics if needed.